← Leaderboards
Douglas Craig Hooper
Thomas Jefferson University
$5,179,858
Attributed
$8,691,161
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2006–15$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$8,691,161 · 6
By mechanism
R01$5,506,580 · 2
U01$1,950,004 · 1
R21$1,234,577 · 3
Top collaborators
- Zhen F Fu5 shared
- Rodney E Willoughby5 shared
- Songming Chen4 shared
- Patrick Robert Romano1 shared
Most similar at Thomas Jefferson University
Same institution · by research overlap
- Walter John Curran$19,392,586
- Harris Goldstein$29,313,609
- Carlo M Croce$37,904,390
- Abdolmohamad Rostami$26,076,182
- Jay S Schneider$22,871,022
Others in their field
Top investigators on “Mediating”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Lawrence Corey · Fred Hutchinson Cancer Center$493,822,581
- Barton F Haynes · Duke University$295,802,493
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$286,700,869
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$176,977,598
- Dan H. Barouch · Fred Hutchinson Cancer Center$122,734,499
Research focus
MediatingTissuesBlood - Brain Barrier AnatomyResponseCellsImmunityInfectionImmuneVirus DiseasesImmune ResponseVirusRabies VirusNeuronsRabiesVirus ReplicationNeutralizing AntibodyProphylactic TreatmentAnimalsPreventBaseChiropteraNeurotropic VirusAstrocytesProduction
Grant awards (20)
Virus Clearance from the Central Nervous System$945,437
R01 · FY2015 · AI · contact PI
Virus Clearance from the Central Nervous System$945,437
R01 · FY2014 · AI · contact PI
Virus Clearance from the Central Nervous System$888,709
R01 · FY2013 · AI · contact PI
Host-pathogen competition in IFN mediated antiviral defense$370,916
U01 · FY2013 · AI · contact PI
Virus Clearance from the Central Nervous System$945,437
R01 · FY2012 · AI · contact PI
Host-pathogen competition in IFN mediated antiviral defense$394,593
U01 · FY2012 · AI · contact PI
Virus Clearance from the Central Nervous System$956,718
R01 · FY2011 · AI · contact PI
Host-pathogen competition in IFN mediated antiviral defense$394,751
U01 · FY2011 · AI · contact PI
Host-pathogen competition in IFN mediated antiviral defense$398,723
U01 · FY2010 · AI · contact PI
Host-pathogen competition in IFN mediated antiviral defense$391,021
U01 · FY2009 · AI · contact PI
Passive Immunization for Neurotropic Virus Infection$266,096
R01 · FY2009 · AI · contact PI
Passive Immunization for Neurotropic Virus Infection$21,400
R01 · FY2009 · AI · contact PI
Passive Immunization for Neurotropic Virus Infection$266,096
R01 · FY2008 · AI · contact PI
Maintenance of Blood-Brain Barrier Integrity as a Neurotropic Virus Immunizaiton$190,069
R21 · FY2008 · AI · contact PI
Passive Immunization for Neurotropic Virus Infection$271,250
R01 · FY2007 · AI · contact PI
Maintenance of Blood-Brain Barrier Integrity as a Neurotropic Virus Immunizaiton$232,500
R21 · FY2007 · AI · contact PI
Uric Acid: An Alternative Approach to the Prevention of Spinal Cord Injury?$225,758
R21 · FY2007 · AT · contact PI
Uric Acid: An Alternative Approach to the Prevention of Spinal Cord Injury?$193,750
R21 · FY2006 · AT · contact PI
Inosine in the over-the-counter treatment of MS$196,250
R21 · FY2004 · AT
Inosine in the over-the-counter treatment of MS$196,250
R21 · FY2003 · AT